MitoMap: Difference between revisions
Content deleted Content added
Citation bot (talk | contribs) m Add: title. Converted bare reference to cite template. You can use this bot yourself. Report bugs here. | User-activated; Category:Bioinformatics. |
m Normalize {{Multiple issues}}: Remove {{Multiple issues}} for only 1 maintenance template(s): Notability |
||
| Line 1: | Line 1: | ||
{{multiple issues| |
|||
{{Orphan|date=November 2014}} |
{{Orphan|date=November 2014}} |
||
{{notability|Companies|date=November 2014}} |
{{notability|Companies|date=November 2014}} |
||
}} |
|||
{{Infobox company |
{{Infobox company |
||
Revision as of 19:08, 31 May 2020
 | The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. (November 2014) |
| Company type | Real Time Sequencing |
|---|---|
| Industry | Genomics and R&D |
| Founded | Delhi, India (2013) |
| Founder | NGBT Conference |
| Headquarters | Delhi, India |
| Website | mitomap |
MitoMap is a real time haplotyping protocol that analyzes pathogenic variants that cause several mitochondrial diseases.[1] It was carried out real-time for the first time during the 2013 NexGen Genomics & Bioinformatics Technologies conference at Delhi, India from November 14–16. The results have been published online.[2]